Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer

Figure 3

Increased nuclear survivin predicts outcome in ER-positive patients. (A) Kaplan-Meier estimation of OS and BCSS comparing ER-positive patients with high and low CNR, as defined by the decision tree prognostic model. (B) Kaplan-Meier estimation of OS and BCSS comparing ER-positive patients with high and low SNAS, as defined by the decision tree prognostic model.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us